Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pavoine

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Nature|February 12, 1987
A glucagon fragment is responsible for the inhibition of the liver Ca2+ pump by glucagonA Mallat, C Pavoine, M Dufour, et al.
The Journal of Biological Chemistry|March 5, 1987
Cholera toxin blocks glucagon-mediated inhibition of the liver plasma membrane (Ca2+-Mg2+)-ATPaseS Lotersztajn, C Pavoine, A Mallat, et al.
The Biochemical Journal|March 15, 1990
Inhibition of the calcium pump by human parathyroid hormone-(1-34) and human calcitonin in liver plasma membranesR C McKenzie, S Lotersztajn, C Pavoine, et al.
The Journal of Biological Chemistry|June 15, 1990
Glucagon-(19-29) exerts a biphasic action on the liver plasma membrane Ca2+ pump which is mediated by G proteinsS Lotersztajn, C Pavoine, V Brechler, et al.
Advances in Experimental Medicine and Biology|January 1, 1985
Protein kinase C and granule release in human plateletsM Castagna, R Brasseur, C Pavoine, et al.
The American Journal of Physiology|May 1, 1991
Miniglucagon [glucagon-(19-29)] is a component of the positive inotropic effect of glucagonC Pavoine, V Brechler, A Kervran, et al.
The Journal of Biological Chemistry|August 14, 1999
Biological effects of C-type natriuretic peptide in human myofibroblastic hepatic stellate cellsJ Tao, A Mallat, C Gallois, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 10, 2001
Adult cardiac myocytes survive and remain excitable during long-term culture on synthetic supportsT A Folliguet, C Rücker-Martin, C Pavoine, et al.
The Journal of Biological Chemistry|December 15, 1990
Glucagon-(19-29), a Ca2+ pump inhibitory peptide, is processed from glucagon in the rat liver plasma membrane by a thiol endopeptidaseP Blache, A Kervran, M Dufour, et al.
The Journal of Biological Chemistry|February 5, 1992
Role of G protein beta gamma subunits in the regulation of the plasma membrane Ca2+ pumpS Lotersztajn, C Pavoine, P Deterre, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Nature|February 12, 1987
A glucagon fragment is responsible for the inhibition of the liver Ca2+ pump by glucagonA Mallat, C Pavoine, M Dufour, et al.
The Journal of Biological Chemistry|March 5, 1987
Cholera toxin blocks glucagon-mediated inhibition of the liver plasma membrane (Ca2+-Mg2+)-ATPaseS Lotersztajn, C Pavoine, A Mallat, et al.
The Biochemical Journal|March 15, 1990
Inhibition of the calcium pump by human parathyroid hormone-(1-34) and human calcitonin in liver plasma membranesR C McKenzie, S Lotersztajn, C Pavoine, et al.
The Journal of Biological Chemistry|June 15, 1990
Glucagon-(19-29) exerts a biphasic action on the liver plasma membrane Ca2+ pump which is mediated by G proteinsS Lotersztajn, C Pavoine, V Brechler, et al.
Advances in Experimental Medicine and Biology|January 1, 1985
Protein kinase C and granule release in human plateletsM Castagna, R Brasseur, C Pavoine, et al.
The American Journal of Physiology|May 1, 1991
Miniglucagon [glucagon-(19-29)] is a component of the positive inotropic effect of glucagonC Pavoine, V Brechler, A Kervran, et al.
The Journal of Biological Chemistry|August 14, 1999
Biological effects of C-type natriuretic peptide in human myofibroblastic hepatic stellate cellsJ Tao, A Mallat, C Gallois, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 10, 2001
Adult cardiac myocytes survive and remain excitable during long-term culture on synthetic supportsT A Folliguet, C Rücker-Martin, C Pavoine, et al.
The Journal of Biological Chemistry|December 15, 1990
Glucagon-(19-29), a Ca2+ pump inhibitory peptide, is processed from glucagon in the rat liver plasma membrane by a thiol endopeptidaseP Blache, A Kervran, M Dufour, et al.
The Journal of Biological Chemistry|February 5, 1992
Role of G protein beta gamma subunits in the regulation of the plasma membrane Ca2+ pumpS Lotersztajn, C Pavoine, P Deterre, et al.
Pageof 4